imipramine has been researched along with Anxiety in 203 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
Anxiety: Feelings or emotions of dread, apprehension, and impending disaster but not disabling as with ANXIETY DISORDERS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "A noninvasive measure was used to assess the effects of alprazolam, imipramine and placebo on parasympathetic (vagal) cardiac control following 6-weeks of medication in patients with generalized anxiety disorder." | 9.07 | Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder. ( Hoehn-Saric, R; McLeod, DR; Porges, SW; Zimmerli, WD, 1992) |
| "The reactivity of 40 panic disorder patients on mental arithmetic, cold pressor, and 5% CO2 inhalation stressors was tested before and after 8 weeks of treatment with imipramine, alprazolam, or placebo." | 9.07 | Imipramine and alprazolam effects on stress test reactivity in panic disorder. ( Agras, WS; Ehlers, A; Haddad, JM; Maddock, RJ; Margraf, J; Roth, WT; Taylor, CB, 1992) |
| " Twenty-eight inpatients with a diagnosis of endogenous depression received either trazodone, imipramine, or placebo." | 9.04 | Trazodone, a new antidepressant: efficacy and safety in endogenous depression. ( Kellams, JJ; Klapper, MH; Small, JG, 1979) |
| "Considering that serotoninergic agents attenuate symptoms of anxiety and are used to treat depression, we investigated whether subchronic treatment with imipramine, a serotonin/noradrenaline reuptake inhibitor, would prevent the anxiogenic-like behaviour induced by acute and/or chronic ethanol withdrawal." | 8.02 | Imipramine attenuates anxiety- and depressive-like effects of acute and prolonged ethanol-abstinence in male rats by modulating SERT and GR expression in the dorsal hippocampus. ( Anselmo-Franci, JA; Campos-Cardoso, R; Carolino, ROG; Padovan, CM; Silva, CPB; Tirapelli, CR, 2021) |
| " Imipramine treatment was able to reverse depressive- and anxiety-like behaviors." | 7.91 | Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion. ( Barichello, T; Ceretta, RA; Dal-Pizzol, F; Dominguini, D; Generoso, JS; Michels, M; Netto, S; Réus, GZ; Simões, LR; Valim, RF; Valvassori, SS, 2019) |
| "In order to relieve anxiety and depression accompanying stress, physicians resort to tricyclic antidepressants, such as imipramine." | 7.83 | Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors. ( Ramirez, K; Sheridan, JF, 2016) |
| "A dysregulated hypothalamic-pituitary-adrenal axis (HPA) has been implicated in major depressive disorder and most commonly used animal models of depression have been shown to elevate circulating levels of plasma corticosterone." | 7.74 | Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. ( Hutson, PH; Murray, F; Smith, DW, 2008) |
| "Platelet [3H]imipramine binding was measured in 40 migrainous (7 classical and 33 common) and 17 tension headache patients and in 28 normal controls." | 7.68 | Platelet [3H]imipramine binding in migraine and tension headache in relation to depression. ( Davies, PT; Fernandez, M; Glover, V; Jarman, J; Rose, FC; Sandler, M; Steiner, TJ, 1991) |
| " The compounds chosen are likely to produce anxiety by activity at different sites in the central nervous system: yohimbine, by blocking the alpha 2-adrenoceptor; FG 7142, by action at the beta-carboline site on the GABA-benzodiazepine receptor complex and pentylenetetrazole, by acting at the picrotoxinin site on this complex." | 7.67 | Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. ( File, SE; Johnston, AL, 1987) |
| "A growing body of evidence has focused on the impact of mitochondrial disturbances in the development of depression, but little data exist regarding the effects of chronic administration of antidepressant drugs on the brain's mitochondrial protein profile." | 5.43 | The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression. ( Basta-Kaim, A; Budziszewska, B; Głombik, K; Kubera, M; Lasoń, W; Olszanecki, R; Ślusarczyk, J; Spedding, M; Stachowicz, A; Trojan, E, 2016) |
| "Curcumin is a biologically active phytochemical presents in turmeric and has pharmacological actions that benefit patients with depression and anxiety." | 5.42 | The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. ( Li, J; Pan, J; Wang, R; Wu, S; Xie, X; Xu, Y; Yu, X; Yu, Y; Zheng, L, 2015) |
| "A double-blind, placebo-controlled study of 229 patients with a Research Diagnostic Criteria diagnosis of major, minor or intermittent depression was used to compare the clinical profiles of venlafaxine and imipramine in general practice." | 5.08 | Efficacy of venlafaxine in depressive illness in general practice. ( Blanchard, C; Bourin, M; Danjou, P; Hackett, D; Lecrubier, Y; Moon, CA; Schifano, F, 1997) |
| " Because imipramine has lowered T4 in uncontrolled studies we examined the effect of imipramine on serum thyroid levels in panic disorder patients in a double-blind placebo and diazepam treatment controlled study." | 5.07 | The changes of thyroid hormone during pharmacological treatment of panic disorder patients. ( Balon, R; Glitz, DA; Pohl, R; Ramesh, C; Yeragani, VK, 1991) |
| "A noninvasive measure was used to assess the effects of alprazolam, imipramine and placebo on parasympathetic (vagal) cardiac control following 6-weeks of medication in patients with generalized anxiety disorder." | 5.07 | Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder. ( Hoehn-Saric, R; McLeod, DR; Porges, SW; Zimmerli, WD, 1992) |
| "The reactivity of 40 panic disorder patients on mental arithmetic, cold pressor, and 5% CO2 inhalation stressors was tested before and after 8 weeks of treatment with imipramine, alprazolam, or placebo." | 5.07 | Imipramine and alprazolam effects on stress test reactivity in panic disorder. ( Agras, WS; Ehlers, A; Haddad, JM; Maddock, RJ; Margraf, J; Roth, WT; Taylor, CB, 1992) |
| " Twenty-eight inpatients with a diagnosis of endogenous depression received either trazodone, imipramine, or placebo." | 5.04 | Trazodone, a new antidepressant: efficacy and safety in endogenous depression. ( Kellams, JJ; Klapper, MH; Small, JG, 1979) |
| "Considering that serotoninergic agents attenuate symptoms of anxiety and are used to treat depression, we investigated whether subchronic treatment with imipramine, a serotonin/noradrenaline reuptake inhibitor, would prevent the anxiogenic-like behaviour induced by acute and/or chronic ethanol withdrawal." | 4.02 | Imipramine attenuates anxiety- and depressive-like effects of acute and prolonged ethanol-abstinence in male rats by modulating SERT and GR expression in the dorsal hippocampus. ( Anselmo-Franci, JA; Campos-Cardoso, R; Carolino, ROG; Padovan, CM; Silva, CPB; Tirapelli, CR, 2021) |
| " Imipramine treatment was able to reverse depressive- and anxiety-like behaviors." | 3.91 | Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion. ( Barichello, T; Ceretta, RA; Dal-Pizzol, F; Dominguini, D; Generoso, JS; Michels, M; Netto, S; Réus, GZ; Simões, LR; Valim, RF; Valvassori, SS, 2019) |
| "In order to relieve anxiety and depression accompanying stress, physicians resort to tricyclic antidepressants, such as imipramine." | 3.83 | Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors. ( Ramirez, K; Sheridan, JF, 2016) |
| "Thus, our results suggest that the reduced IL-4 and IL-10 levels in serum with hippocampal M2 markers may be involved in the stress vulnerability after imipramine discontinuation, and the restoration and modulation of these factors may be useful to some forms of depression-associated conditions." | 3.81 | IL-4/10 prevents stress vulnerability following imipramine discontinuation. ( Choi, HJ; Han, A; Hong, CW; Kim, SH; Kwon, MS; Park, MJ; Yeo, H, 2015) |
| " Here, sucrose intake, forced swimming, immobility in the modified tail suspension test, novelty exploration, grooming, anxiety and locomotor activity were compared in naïve 3- and 18-month-old male C57BL/6 mice." | 3.78 | Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: Implications for modeling elderly depression. ( Bachurin, S; Bolkunov, A; Kubatiev, A; Malatynska, E; Redkozubova, O; Steinbusch, HW; Strekalova, T; Vignisse, J; Yeritsyan, NB, 2012) |
| "Imipramine treatment decreased anxiety levels in females, but not in males, in the normal weaning condition." | 3.78 | Effects of sex and rearing environment on imipramine response in mice. ( Kikusui, T; Mogi, K; Nagasawa, M; Shimokawa, Y, 2012) |
| "A dysregulated hypothalamic-pituitary-adrenal axis (HPA) has been implicated in major depressive disorder and most commonly used animal models of depression have been shown to elevate circulating levels of plasma corticosterone." | 3.74 | Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice. ( Hutson, PH; Murray, F; Smith, DW, 2008) |
| " The aim of this study was to compare the behavioural effects of NOS inhibitor 7-nitroindazole (7-NI) with the more selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)imidazole (TRIM) in animal models predictive of antidepressant- and anxiolytic-like activity in order to clarify the role of distinct isoforms of NOS in the regulation of depression and anxiety." | 3.72 | Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. ( Bourin, M; Vasar, E; Volke, V; Wegener, G, 2003) |
| " Syt IV (-/-) mice also exhibit reduced depression-like behavior and are highly sensitive to the effects of the anti-depressant imipramine in a modified Porsolt forced swim test." | 3.72 | Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice. ( Ferguson, GD; Herschman, HR; Storm, DR, 2004) |
| "The escape behaviour induced in rats by injecting D,L-homocysteic acid (DHL) into the dorsal periaqueductal grey area (DPAG) was used as an animal model of panic attacks to investigate the effect of imipramine, a drug used for the treatment of panic disorder, on the sensitivity of 5-HT1A receptors in the DPAG." | 3.69 | Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats. ( Marsden, CA; Mongeau, R, 1997) |
| "Recent clinical evidence suggests that the tricyclic antidepressant imipramine is effective against not only panic disorder but also generalized anxiety disorder." | 3.69 | Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze. ( Cole, JC; Rodgers, RJ, 1995) |
| " The tricyclic antidepressant imipramine may be as effective as anxiolytic drugs in treatment of generalized anxiety disorder." | 3.69 | A comparison of the acute effects of a tricyclic and a MAOI antidepressant on septal driving of hippocampal rhythmical slow activity. ( McNaughton, N; Zhu, XO, 1994) |
| "This study investigated behavioural effects of very potent 5-HT reuptake inhibitors after acute treatment (cianopramine and citalopram), as well as after chronic treatment (cianopramine), in two behavioural models of anxiety: 1) the light/dark choice procedure in mice and 2) the elevated plus-maze test in rats." | 3.69 | Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents. ( Griebel, G; Jenck, F; Martin, JR; Misslin, R; Moreau, JL, 1994) |
| "Platelet [3H]imipramine binding was measured in 40 migrainous (7 classical and 33 common) and 17 tension headache patients and in 28 normal controls." | 3.68 | Platelet [3H]imipramine binding in migraine and tension headache in relation to depression. ( Davies, PT; Fernandez, M; Glover, V; Jarman, J; Rose, FC; Sandler, M; Steiner, TJ, 1991) |
| " The compounds chosen are likely to produce anxiety by activity at different sites in the central nervous system: yohimbine, by blocking the alpha 2-adrenoceptor; FG 7142, by action at the beta-carboline site on the GABA-benzodiazepine receptor complex and pentylenetetrazole, by acting at the picrotoxinin site on this complex." | 3.67 | Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat. ( File, SE; Johnston, AL, 1987) |
| "Imipramine was more effective against the clusters related to core symptoms of depression: "depression and guilt", "retardation", and "melancholia", respectively." | 2.69 | Depressed in-patients respond differently to imipramine and mirtazapine. ( Bruijn, JA; Moleman, P; Mulder, PG; van den Broek, WW, 1999) |
| " Side effects were assessed through the Dosage Record Emergent Symptoms at days 0, 7, 14, 30, 45, and 60." | 2.67 | Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine. ( Delle Chiaie, R; Donnini, M; Gambino, C; Pancheri, P; Seripa, S; Trillo, L; Vicario, E, 1994) |
| "The alprazolam effects were apparent by week 1; the imipramine effects by week 4." | 2.67 | Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial. ( Agras, WS; Clark, D; Ehlers, A; Hayward, C; King, R; Maddock, R; Margraf, J; Roth, WT; Taylor, CB, 1990) |
| "Endogenous anxiety (anxiety hysteria, agoraphobia with panic attacks) is characterized by sudden, spontaneous panic attacks accompanied by multiple autonomic symptoms, overwhelming fear, a flight response, and polyphobic behavior." | 2.65 | Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms. ( Ballenger, J; Jacobsen, G; Sheehan, DV, 1980) |
| "Chlorpromazine was the most efficacious treatment for black women, whereas imipramine was most efficacious for black men." | 2.64 | Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine. ( Crook, TH; Raskin, A, 1975) |
| " Chronic administration of imipramine (15 mg/kg, ip, 21 days) caused an anxiolytic effect in the elevated T-maze and light-dark transition tests, which was not blocked by previous infusion of SB-242084 into the DH." | 1.51 | Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats. ( de Andrade, TGCS; Hernandes, PM; Sant'Ana, AB; Vicente, MA; Vilela-Costa, HH; Zangrossi, H, 2019) |
| "The present work aims to investigate the anxiolytic activity of 6-styryl-2-pyrone (STY), obtained from Aniba panurensis, in behavioral tests and amino acids dosage on male Swiss mice." | 1.48 | The anxiolytic-like effect of 6-styryl-2-pyrone in mice involves GABAergic mechanism of action. ( Barbosa-Filho, JM; Chaves, EMC; Dantas, LP; Honório-Júnior, JER; Lúcio, ASSC; Monteiro, VS; Nonato, DTT; Patrocínio, MCA; Sousa, CNS; Vasconcelos, SMM; Viana, GSB, 2018) |
| "A growing body of evidence has focused on the impact of mitochondrial disturbances in the development of depression, but little data exist regarding the effects of chronic administration of antidepressant drugs on the brain's mitochondrial protein profile." | 1.43 | The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression. ( Basta-Kaim, A; Budziszewska, B; Głombik, K; Kubera, M; Lasoń, W; Olszanecki, R; Ślusarczyk, J; Spedding, M; Stachowicz, A; Trojan, E, 2016) |
| "Curcumin is a biologically active phytochemical presents in turmeric and has pharmacological actions that benefit patients with depression and anxiety." | 1.42 | The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling. ( Li, J; Pan, J; Wang, R; Wu, S; Xie, X; Xu, Y; Yu, X; Yu, Y; Zheng, L, 2015) |
| "Ketamine is an anesthetic with antidepressant properties." | 1.42 | The positive effect on ketamine as a priming adjuvant in antidepressant treatment. ( Dalla, C; Ferreira, C; Kokras, N; Melo, A; Pêgo, JM; Sousa, N; Ventura-Silva, AP, 2015) |
| "Pretreatment with imipramine (10 and 20mg/kg) and venlafaxine (5 and 10mg/kg) significantly reversed immobilized stress-induced behavioral and biochemical alterations." | 1.35 | Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice. ( Garg, R; Gaur, V; Kumar, A; Kumar, P, 2009) |
| "These results suggest that chronic administration of the hydroalcoholic extract of the stem bark of Erythrina velutina exerts an anxiolytic-like effect on mice, and it could serve as a new approach for the treatment anxiety, although it may have an amnesic effect at low doses." | 1.35 | Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test. ( Andreatini, R; Cavalcanti E Silva, EL; Ghislandi, C; Miguel, OG; Raupp, IM; Sereniki, A; Trebien, HA; Virtuoso, S, 2008) |
| " Dose-response studies using two classes of anxiolytics (chlordiazepoxide: 2." | 1.35 | Modelling the anxiety-depression continuum in chicks. ( Acevedo, EO; Huang, CJ; Sufka, KJ; Warnick, JE, 2009) |
| " These results indicate that SNAP 94847 has a unique anxiolytic-like profile after both acute and chronic administration and that its mechanism of action is distinct from that of selective serotonin reuptake inhibitors and tricyclic antidepressants." | 1.34 | Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocam ( Craig, DA; David, DJ; Dong, D; Gerald, CP; Hegde, LG; Hen, R; Holick, KA; Klemenhagen, KC; Marzabadi, MR; Mendez, I; Ping, XI; Santarelli, L; Saxe, MD; Swanson, CJ; Zhong, H, 2007) |
| "Anxiety and depression are currently classified as separate clinical syndromes despite considerable similarities in their symptoms, pathophysiological substrates and response to treatment interventions." | 1.33 | Modeling the anxiety-depression continuum hypothesis in domestic fowl chicks. ( Acevedo, EO; Cartwright, CM; Feltenstein, MW; Sufka, KJ; Warnick, JE; Webb, HE, 2006) |
| "Treatment with imipramine (3 x 30 mg/kg i." | 1.32 | Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances? ( Allain, H; Amiot, N; Bantsiele, GB; Bentué-Ferrer, D; Bourin, M; Reymann, JM, 2004) |
| " Long-term administration with imipramine or mirtazapine (10 mg/kg, i." | 1.31 | Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats. ( Biggio, G; Dazzi, L; Ladu, S; Pira, L; Rivano, A; Spiga, F; Vacca, G, 2002) |
| "Imipramine treatment was maintained on a daily basis during the 7 days taken to complete the series of tests." | 1.29 | Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine. ( Blanchard, DC; Blanchard, RJ; Magee, L; Rodgers, RJ; Shepherd, JK, 1993) |
| " In addition, long-term administration with both SRIs produced a reliable attenuation of predator assessment activities." | 1.29 | Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine. ( Agnes, RS; Blanchard, DC; Blanchard, RJ; Griebel, G, 1995) |
| "Forty-six patients with various forms of endogenous depression were treated by night sleep deprivation (NSD) which was used as the cardinal method of treatment." | 1.27 | [Sleep deprivation as a method of treating endogenous depression]. ( Fakturovich, AIa; Vovin, RIa, 1985) |
| "The effect of acute or chronic administration of imipramine on fear-enhanced startle (potentiated startle) in rats was investigated." | 1.27 | Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats. ( Cassella, JV; Davis, M, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 114 (56.16) | 18.7374 |
| 1990's | 22 (10.84) | 18.2507 |
| 2000's | 34 (16.75) | 29.6817 |
| 2010's | 29 (14.29) | 24.3611 |
| 2020's | 4 (1.97) | 2.80 |
| Authors | Studies |
|---|---|
| Zajdel, P | 1 |
| Subra, G | 1 |
| Bojarski, AJ | 2 |
| Duszyńska, B | 1 |
| Tatarczyńska, E | 3 |
| Nikiforuk, A | 4 |
| Chojnacka-Wójcik, E | 2 |
| Pawłowski, M | 1 |
| Martinez, J | 1 |
| Kuran, B | 1 |
| Kossakowski, J | 1 |
| Kozioł, A | 1 |
| Jagiełło-Wójtowicz, E | 1 |
| Chodkowska, A | 1 |
| Lewellyn, K | 1 |
| Bialonska, D | 1 |
| Loria, MJ | 1 |
| White, SW | 1 |
| Sufka, KJ | 5 |
| Zjawiony, JK | 1 |
| Naguy, A | 1 |
| Reddy, BR | 1 |
| Babu, NS | 1 |
| Das, T | 1 |
| Bhattacharya, D | 1 |
| Murthy, CLN | 1 |
| Kumar, A | 3 |
| Idris, MM | 1 |
| Chakravarty, S | 2 |
| Campos-Cardoso, R | 1 |
| Silva, CPB | 1 |
| Carolino, ROG | 1 |
| Anselmo-Franci, JA | 1 |
| Tirapelli, CR | 1 |
| Padovan, CM | 1 |
| Duric, V | 1 |
| Banasr, M | 1 |
| Franklin, T | 1 |
| Lepack, A | 1 |
| Adham, N | 1 |
| Kiss, B | 1 |
| Gyertyán, I | 1 |
| Duman, RS | 1 |
| da Cruz, KR | 1 |
| Turones, LC | 1 |
| Camargo-Silva, G | 1 |
| Gomes, KP | 1 |
| Mendonça, MM | 1 |
| Galdino, P | 1 |
| Rodrigues-Silva, C | 1 |
| Santos, RAS | 1 |
| Costa, EA | 1 |
| Ghedini, PC | 1 |
| Ianzer, D | 1 |
| Xavier, CH | 1 |
| Chaves, EMC | 1 |
| Honório-Júnior, JER | 1 |
| Sousa, CNS | 1 |
| Monteiro, VS | 1 |
| Nonato, DTT | 1 |
| Dantas, LP | 1 |
| Lúcio, ASSC | 1 |
| Barbosa-Filho, JM | 1 |
| Patrocínio, MCA | 1 |
| Viana, GSB | 1 |
| Vasconcelos, SMM | 1 |
| Menard, C | 1 |
| Pfau, ML | 1 |
| Hodes, GE | 1 |
| Kana, V | 1 |
| Wang, VX | 1 |
| Bouchard, S | 1 |
| Takahashi, A | 1 |
| Flanigan, ME | 1 |
| Aleyasin, H | 1 |
| LeClair, KB | 1 |
| Janssen, WG | 1 |
| Labonté, B | 1 |
| Parise, EM | 1 |
| Lorsch, ZS | 1 |
| Golden, SA | 1 |
| Heshmati, M | 1 |
| Tamminga, C | 1 |
| Turecki, G | 1 |
| Campbell, M | 1 |
| Fayad, ZA | 1 |
| Tang, CY | 1 |
| Merad, M | 1 |
| Russo, SJ | 1 |
| Rahmani, G | 1 |
| Farajdokht, F | 1 |
| Mohaddes, G | 1 |
| Babri, S | 1 |
| Ebrahimi, V | 1 |
| Ebrahimi, H | 1 |
| Simões, LR | 1 |
| Netto, S | 1 |
| Generoso, JS | 1 |
| Ceretta, RA | 1 |
| Valim, RF | 1 |
| Dominguini, D | 1 |
| Michels, M | 1 |
| Réus, GZ | 1 |
| Valvassori, SS | 1 |
| Dal-Pizzol, F | 1 |
| Barichello, T | 1 |
| Sant'Ana, AB | 1 |
| Vilela-Costa, HH | 1 |
| Vicente, MA | 2 |
| Hernandes, PM | 1 |
| de Andrade, TGCS | 1 |
| Zangrossi, H | 4 |
| Herbst, LS | 1 |
| Gaigher, T | 1 |
| Siqueira, AA | 1 |
| Joca, SRL | 1 |
| Sampaio, KN | 1 |
| Beijamini, V | 1 |
| Yu, Y | 1 |
| Wu, S | 1 |
| Li, J | 1 |
| Wang, R | 1 |
| Xie, X | 1 |
| Yu, X | 1 |
| Pan, J | 1 |
| Xu, Y | 1 |
| Zheng, L | 1 |
| Erburu, M | 1 |
| Cajaleon, L | 1 |
| Guruceaga, E | 1 |
| Venzala, E | 1 |
| Muñoz-Cobo, I | 1 |
| Beltrán, E | 1 |
| Puerta, E | 1 |
| Tordera, RM | 1 |
| Melo, A | 1 |
| Kokras, N | 1 |
| Dalla, C | 1 |
| Ferreira, C | 1 |
| Ventura-Silva, AP | 1 |
| Sousa, N | 1 |
| Pêgo, JM | 1 |
| Schiavon, AP | 1 |
| Bonato, JM | 1 |
| Milani, H | 1 |
| Guimarães, FS | 1 |
| Weffort de Oliveira, RM | 1 |
| Han, A | 1 |
| Yeo, H | 1 |
| Park, MJ | 1 |
| Kim, SH | 1 |
| Choi, HJ | 1 |
| Hong, CW | 1 |
| Kwon, MS | 1 |
| Głombik, K | 1 |
| Stachowicz, A | 1 |
| Olszanecki, R | 1 |
| Ślusarczyk, J | 1 |
| Trojan, E | 1 |
| Lasoń, W | 1 |
| Kubera, M | 1 |
| Budziszewska, B | 1 |
| Spedding, M | 1 |
| Basta-Kaim, A | 1 |
| Ramirez, K | 1 |
| Sheridan, JF | 1 |
| Carpenter, JM | 1 |
| Jourdan, MK | 1 |
| Fountain, EM | 1 |
| Ali, Z | 1 |
| Abe, N | 1 |
| Khan, IA | 1 |
| Warnick, JE | 2 |
| Huang, CJ | 1 |
| Acevedo, EO | 2 |
| Raupp, IM | 1 |
| Sereniki, A | 1 |
| Virtuoso, S | 1 |
| Ghislandi, C | 1 |
| Cavalcanti E Silva, EL | 1 |
| Trebien, HA | 1 |
| Miguel, OG | 1 |
| Andreatini, R | 1 |
| Yalcin, I | 1 |
| Belzung, C | 2 |
| Surget, A | 2 |
| Polter, A | 1 |
| Yang, S | 1 |
| Zmijewska, AA | 1 |
| van Groen, T | 1 |
| Paik, JH | 1 |
| Depinho, RA | 1 |
| Peng, SL | 1 |
| Jope, RS | 1 |
| Li, X | 1 |
| Venna, VR | 1 |
| Deplanque, D | 1 |
| Allet, C | 1 |
| Belarbi, K | 1 |
| Hamdane, M | 1 |
| Bordet, R | 1 |
| Basso, AM | 1 |
| Bratcher, NA | 1 |
| Harris, RR | 1 |
| Jarvis, MF | 1 |
| Decker, MW | 1 |
| Rueter, LE | 1 |
| Heijnen, WT | 1 |
| van den Broek, WW | 2 |
| Mulder, PG | 2 |
| Birkenhäger, TK | 1 |
| Wallace, DL | 1 |
| Han, MH | 1 |
| Graham, DL | 1 |
| Green, TA | 1 |
| Vialou, V | 1 |
| Iñiguez, SD | 1 |
| Cao, JL | 1 |
| Kirk, A | 1 |
| Krishnan, V | 1 |
| Neve, RL | 1 |
| Cooper, DC | 1 |
| Bolaños, CA | 1 |
| Barrot, M | 1 |
| McClung, CA | 1 |
| Nestler, EJ | 1 |
| Ibarguen-Vargas, Y | 1 |
| Vourc'h, P | 1 |
| Leman, S | 1 |
| Andres, CR | 1 |
| Gardier, AM | 1 |
| Garg, R | 1 |
| Gaur, V | 1 |
| Kumar, P | 1 |
| dos Santos, L | 1 |
| de Andrade, TG | 1 |
| Graeff, FG | 2 |
| Kolber, BJ | 1 |
| Boyle, MP | 1 |
| Wieczorek, L | 1 |
| Kelley, CL | 1 |
| Onwuzurike, CC | 1 |
| Nettles, SA | 1 |
| Vogt, SK | 1 |
| Muglia, LJ | 1 |
| Hymel, KA | 1 |
| Crespi, F | 1 |
| Furmaga, H | 1 |
| Shah, A | 1 |
| Frazer, A | 1 |
| Diniz, L | 1 |
| Dos Reis, BB | 1 |
| de Castro, GM | 1 |
| Medalha, CC | 1 |
| Viana, MB | 1 |
| Biesdorf, C | 1 |
| Cortez, DA | 1 |
| Audi, EA | 1 |
| Malatynska, E | 1 |
| Steinbusch, HW | 2 |
| Redkozubova, O | 1 |
| Bolkunov, A | 1 |
| Kubatiev, A | 1 |
| Yeritsyan, NB | 1 |
| Vignisse, J | 1 |
| Bachurin, S | 1 |
| Strekalova, T | 2 |
| Khlebnikova, NN | 1 |
| Krupina, NA | 1 |
| Kushnareva, EY | 1 |
| Zolotov, NN | 1 |
| Kryzhanovskii, GN | 1 |
| Mogi, K | 1 |
| Shimokawa, Y | 1 |
| Nagasawa, M | 1 |
| Kikusui, T | 1 |
| Cline, BH | 1 |
| Malin, D | 1 |
| Revishchin, AV | 1 |
| Pavlova, GV | 1 |
| Cespuglio, R | 1 |
| Zanoli, P | 1 |
| Rivasi, M | 1 |
| Baraldi, C | 1 |
| Baraldi, M | 1 |
| Volke, V | 1 |
| Wegener, G | 1 |
| Bourin, M | 3 |
| Vasar, E | 1 |
| DEMAY-LAULAN, M | 1 |
| DEMAY, J | 1 |
| JOSSE, G | 1 |
| LAVOINE, M | 1 |
| SUTTER, JM | 1 |
| PELICIER, Y | 1 |
| SCOTTO, JC | 1 |
| DELPRETTI, M | 1 |
| WHITMAN, RM | 2 |
| HAUSNER, M | 1 |
| DOLEZAL, V | 1 |
| MAGYAR, I | 1 |
| DIMASCIO, A | 2 |
| HENINGER, G | 1 |
| KLERMAN, GL | 1 |
| LANCE, JW | 1 |
| CURRAN, DA | 1 |
| STRAKHOV, AP | 1 |
| TIMOFEEVA, AN | 1 |
| LIPSKAIA, LA | 1 |
| KLEIN, DF | 6 |
| SCHULZE, HA | 1 |
| NEUMANN, J | 1 |
| Carvalho-Netto, EF | 1 |
| Nunes-de-Souza, RL | 1 |
| Aricioglu, F | 2 |
| Altunbas, H | 2 |
| Ferguson, GD | 1 |
| Herschman, HR | 1 |
| Storm, DR | 1 |
| Bantsiele, GB | 1 |
| Bentué-Ferrer, D | 1 |
| Amiot, N | 1 |
| Allain, H | 1 |
| Reymann, JM | 1 |
| Kłodzińska, A | 1 |
| Stachowicz, K | 3 |
| Zanoveli, JM | 1 |
| Nogueira, RL | 1 |
| Hinojosa, FR | 1 |
| Spricigo, L | 1 |
| Izídio, GS | 1 |
| Brüske, GR | 1 |
| Lopes, DM | 1 |
| Ramos, A | 1 |
| Wesołowska, A | 3 |
| Feltenstein, MW | 1 |
| Webb, HE | 1 |
| Cartwright, CM | 1 |
| David, DJ | 1 |
| Klemenhagen, KC | 1 |
| Holick, KA | 1 |
| Saxe, MD | 1 |
| Mendez, I | 1 |
| Santarelli, L | 1 |
| Craig, DA | 1 |
| Zhong, H | 1 |
| Swanson, CJ | 1 |
| Hegde, LG | 1 |
| Ping, XI | 1 |
| Dong, D | 1 |
| Marzabadi, MR | 1 |
| Gerald, CP | 1 |
| Hen, R | 1 |
| Murray, F | 1 |
| Smith, DW | 1 |
| Hutson, PH | 1 |
| Lowinger, P | 1 |
| Dobie, S | 1 |
| Reid, S | 1 |
| Rainey, M | 1 |
| Ettedgui, E | 1 |
| Pohl, B | 1 |
| Balon, R | 3 |
| Weinberg, P | 1 |
| Yelonek, S | 1 |
| Berchou, R | 2 |
| Kato, G | 1 |
| Ban, TA | 2 |
| Mavissakalian, M | 2 |
| Michelson, L | 2 |
| Yoshimura, H | 1 |
| Ogawa, N | 1 |
| Dealy, RS | 1 |
| Petit, M | 2 |
| Friedman, MJ | 1 |
| Stolk, JM | 1 |
| Harris, PQ | 1 |
| Cooper, TB | 1 |
| Petrie, WM | 1 |
| McEvoy, JP | 1 |
| Wilson, WH | 1 |
| Guy, W | 1 |
| Kaplan, HS | 1 |
| Fyer, AJ | 1 |
| Novick, A | 1 |
| Sheehan, DV | 1 |
| Ballenger, J | 1 |
| Jacobsen, G | 1 |
| Griebel, G | 3 |
| Blanchard, DC | 2 |
| Agnes, RS | 1 |
| Blanchard, RJ | 2 |
| Zhu, XO | 1 |
| McNaughton, N | 1 |
| Moreau, JL | 1 |
| Jenck, F | 1 |
| Misslin, R | 1 |
| Martin, JR | 1 |
| Shepherd, JK | 1 |
| Rodgers, RJ | 2 |
| Magee, L | 1 |
| Tanra, AJ | 1 |
| Kagaya, A | 1 |
| Motohashi, N | 1 |
| Uchitomi, Y | 1 |
| Yamawaki, S | 1 |
| Pancheri, P | 1 |
| Delle Chiaie, R | 1 |
| Donnini, M | 1 |
| Seripa, S | 1 |
| Gambino, C | 1 |
| Vicario, E | 1 |
| Trillo, L | 1 |
| Cole, JC | 1 |
| Mongeau, R | 1 |
| Marsden, CA | 1 |
| Lecrubier, Y | 1 |
| Moon, CA | 1 |
| Schifano, F | 1 |
| Blanchard, C | 1 |
| Danjou, P | 1 |
| Hackett, D | 1 |
| Gentsch, C | 1 |
| Hata, T | 1 |
| Nishikawa, H | 1 |
| Itoh, E | 1 |
| Watanabe, A | 1 |
| Bruijn, JA | 1 |
| Moleman, P | 1 |
| Silvestre, JS | 1 |
| Fernández, AG | 1 |
| Palacios, JM | 1 |
| Teixeira, RC | 1 |
| Podhorna, J | 1 |
| Brown, RE | 1 |
| Bertani, A | 1 |
| Perna, G | 1 |
| Arancio, C | 1 |
| Caldirola, D | 1 |
| Bellodi, L | 1 |
| Dazzi, L | 2 |
| Spiga, F | 2 |
| Pira, L | 2 |
| Ladu, S | 2 |
| Vacca, G | 2 |
| Rivano, A | 2 |
| Jentsch, JD | 1 |
| Biggio, G | 2 |
| Bukulmez, O | 1 |
| Al, A | 1 |
| Gurdal, H | 1 |
| Yarali, H | 1 |
| Ulug, B | 1 |
| Gurgan, T | 1 |
| Schramm, NL | 1 |
| McDonald, MP | 1 |
| Limbird, LE | 1 |
| Simiand, J | 1 |
| Serradeil-Le Gal, C | 1 |
| Wagnon, J | 1 |
| Pascal, M | 1 |
| Scatton, B | 1 |
| Maffrand, JP | 1 |
| Soubrie, P | 1 |
| Keith, PR | 1 |
| Kissin, B | 2 |
| Berner, P | 1 |
| Zapotoczky, HG | 1 |
| Pinder, RM | 1 |
| Brogden, RN | 1 |
| Speight, TM | 1 |
| Avery, GS | 1 |
| Goldberg, HL | 2 |
| Finnerty, RJ | 2 |
| Kellams, JJ | 1 |
| Klapper, MH | 1 |
| Small, JG | 1 |
| Gold, MS | 1 |
| Pottash, AL | 1 |
| Sweeney, DR | 1 |
| Kleber, HD | 1 |
| Redmond, DE | 1 |
| Liebowitz, MR | 1 |
| Gottlieb, RM | 1 |
| Nappi, T | 1 |
| Strain, JJ | 1 |
| Rickels, K | 2 |
| Singh, AN | 1 |
| Saxena, B | 1 |
| Gent, M | 2 |
| Nelson, HL | 1 |
| Uhlenhuth, EH | 1 |
| Raskin, A | 5 |
| Crook, TH | 2 |
| Woodward, JA | 1 |
| Henry, BW | 1 |
| Overall, JE | 1 |
| Marshall, JR | 1 |
| Ashcroft, GW | 1 |
| Covi, L | 1 |
| Lipman, RS | 1 |
| Alarcon, RD | 1 |
| Smith, VK | 1 |
| Scheibe, G | 1 |
| Nutzinger, D | 1 |
| Buller, R | 1 |
| Walther, AU | 1 |
| Roth, WT | 2 |
| Margraf, J | 2 |
| Ehlers, A | 2 |
| Haddad, JM | 1 |
| Maddock, RJ | 1 |
| Agras, WS | 2 |
| Taylor, CB | 2 |
| McLeod, DR | 1 |
| Hoehn-Saric, R | 1 |
| Porges, SW | 1 |
| Zimmerli, WD | 1 |
| Jarman, J | 1 |
| Davies, PT | 1 |
| Fernandez, M | 1 |
| Glover, V | 1 |
| Steiner, TJ | 1 |
| Rose, FC | 1 |
| Sandler, M | 1 |
| Pohl, R | 2 |
| Yeragani, VK | 1 |
| Ramesh, C | 1 |
| Glitz, DA | 1 |
| Kosten, TR | 1 |
| Frank, JB | 1 |
| Dan, E | 1 |
| McDougle, CJ | 1 |
| Giller, EL | 1 |
| Hayward, C | 1 |
| King, R | 1 |
| Maddock, R | 1 |
| Clark, D | 1 |
| Mitchell, JE | 1 |
| Pyle, RL | 1 |
| Eckert, ED | 1 |
| Hatsukami, D | 1 |
| Pomeroy, C | 1 |
| Zimmerman, R | 1 |
| Borsini, F | 1 |
| Lecci, A | 1 |
| Volterra, G | 1 |
| Meli, A | 1 |
| Pellow, S | 1 |
| File, SE | 2 |
| Rizley, R | 1 |
| Kahn, RJ | 1 |
| McNair, DM | 1 |
| Frankenthaler, LM | 1 |
| Johnston, AL | 1 |
| Dollfus, S | 1 |
| Ananth, J | 1 |
| Cohn, JB | 1 |
| Wilcox, C | 1 |
| Stark, P | 1 |
| Hardison, CD | 1 |
| Vovin, RIa | 1 |
| Fakturovich, AIa | 1 |
| Cassella, JV | 1 |
| Davis, M | 1 |
| Davis, DD | 1 |
| Dunlop, SR | 1 |
| Shea, P | 1 |
| Brittain, H | 1 |
| Hendrie, HC | 1 |
| Rainey, J | 1 |
| Ortiz, A | 1 |
| Singh, H | 1 |
| Hart, FD | 1 |
| Huskisson, EC | 1 |
| Young, GC | 1 |
| Morgan, RT | 1 |
| McClure, DJ | 1 |
| Low, GL | 1 |
| Udabe, RU | 1 |
| Boucard, M | 1 |
| Cahen, R | 1 |
| Faurre, LE | 1 |
| Vedel, Y | 1 |
| Serrano, JJ | 1 |
| Zung, WW | 1 |
| Gross, MM | 1 |
| Greenberg, R | 1 |
| Pearlman, C | 1 |
| Liederman, PC | 1 |
| Green, R | 1 |
| Liederman, VR | 1 |
| Meyer, RE | 1 |
| Stifler, L | 1 |
| Barnett, A | 1 |
| Taber, RI | 1 |
| Roth, FE | 1 |
| Debus, G | 1 |
| Ogura, C | 1 |
| Okuma, T | 1 |
| Uchida, Y | 1 |
| Imai, S | 1 |
| Yogi, H | 1 |
| Schildkraut, JJ | 1 |
| Winsberg, BG | 1 |
| Bialer, I | 2 |
| Kupietz, S | 2 |
| Tobias, J | 1 |
| Chung, HR | 1 |
| Csanalosi, I | 1 |
| Sablosky, L | 1 |
| Simon, JH | 1 |
| Lader, M | 1 |
| Lapierre, YD | 1 |
| Levinson, B | 1 |
| Walcher, W | 1 |
| King, DJ | 1 |
| Wheatley, D | 2 |
| Mendels, J | 1 |
| Digiacomo, J | 1 |
| Reece, RM | 1 |
| Sathananthan, GL | 1 |
| Gershon, S | 1 |
| Falk, MA | 1 |
| Honigfeld, G | 1 |
| Feldman, S | 1 |
| Paykel, ES | 1 |
| Price, JS | 1 |
| Gillan, RU | 1 |
| Palmai, G | 1 |
| Chesser, ES | 1 |
| Verner, JV | 1 |
| Anton, AH | 1 |
| Browne, MW | 1 |
| Kessell, A | 1 |
| Pearce, TA | 1 |
| Holt, NF | 1 |
| Schulterbrandt, JG | 1 |
| Reatig, N | 1 |
| McKeon, JJ | 1 |
| Lader, MH | 1 |
| Silver, LB | 1 |
| Geissmann, P | 1 |
| Geissmann, C | 1 |
| Winsberg, HG | 1 |
| Quitkin, FM | 1 |
| Rifkin, A | 1 |
| Kaplan, J | 1 |
| Heimann, H | 1 |
| Webb, WL | 1 |
| Singh, G | 1 |
| Verma, HC | 1 |
| Gall, H | 1 |
| Madalena, JC | 1 |
| Edwards, G | 1 |
| Gottschalk, LA | 1 |
| Gleser, GC | 1 |
| Wylie, HW | 1 |
| Kaplan, SM | 1 |
| Barkan, DV | 1 |
| Zeidenberg, P | 1 |
| Perel, JM | 1 |
| Kanzler, M | 1 |
| Wharton, RN | 1 |
| Malitz, S | 1 |
| Kramer, M | 1 |
| Baldridge, B | 1 |
| Ornstein, PH | 1 |
| Grater, WC | 1 |
| Mendel, JG | 1 |
| Sargant, W | 1 |
| Walter, CJ | 1 |
| Wright, N | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Acute and Chronic Impacts of Muscadine Wine Polyphenols on Cognition, Memory, Mood, and Anxiety in Adults Over 50 Years of Age[NCT05541887] | 25 participants (Anticipated) | Interventional | 2023-08-30 | Recruiting | |||
| Clinical Study to Investigate the Effect of Administration of Selective Serotonin Reuptake Inhibitors (SSRIs) and an Opioid on Ventilation[NCT05470465] | Phase 1 | 27 participants (Actual) | Interventional | 2022-09-01 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 reviews available for imipramine and Anxiety
| Article | Year |
|---|---|
Doxepin up-to-date: a review of its pharmacological properties and therapeutic efficacy with particular reference to depression.
Topics: Alcoholism; Amitriptyline; Animals; Anxiety; Cardiovascular Diseases; Depression; Doxepin; Drug Inte | 1977 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depressio | 1973 |
The pharmacology of disordered sleep: a laboratory approach.
Topics: Amitriptyline; Anxiety; Arousal; Barbiturates; Brain; Cerebral Cortex; Depression; Desipramine; Huma | 1970 |
Cutting the REM nerve: an approach to the adaptive role of REM sleep.
Topics: Adaptation, Psychological; Animals; Anxiety; Avoidance Learning; Defense Mechanisms; Depression; Ele | 1974 |
Research report: Institute of Psychiatry Clinical Psychopharmacology Research Team.
Topics: Antidepressive Agents; Anxiety; Barbiturates; Conversion Disorder; Depression; Drug Combinations; Dr | 1974 |
Psychopharmacology: a review.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Butyrophenones; Chlordiazepoxide; Chlorprothixene; De | 1968 |
Physiological measures in psychiatry.
Topics: Adaptation, Psychological; Amobarbital; Animals; Anxiety; Arousal; Blood Pressure; Depression; Elect | 1971 |
The neurologic learning disability syndrome.
Topics: Anorexia Nervosa; Anxiety; Attention; Attention Deficit Disorder with Hyperactivity; Brain Damage, C | 1971 |
49 trials available for imipramine and Anxiety
| Article | Year |
|---|---|
Prevalence of trait anxiety in a sample of depressed inpatients and its influence on response to antidepressants.
Topics: Adult; Aged; Antidepressive Agents; Anxiety; Depressive Disorder; Diazepam; Double-Blind Method; Fem | 2010 |
The beta-receptor: isoproterenol anxiety states.
Topics: Adolescent; Adult; Anxiety; Female; Glucose; Humans; Imipramine; Isoproterenol; Lactates; Male; Midd | 1984 |
Tricyclic antidepressants in obsessive-compulsive disorder. Antiobsessional or antidepressant agents?
Topics: Adolescent; Adult; Aged; Anxiety; Clinical Trials as Topic; Clomipramine; Depression; Female; Humans | 1983 |
Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice.
Topics: Adult; Agoraphobia; Anxiety; Behavior Therapy; Combined Modality Therapy; Female; Humans; Imipramine | 1983 |
Viloxazine in the treatment of depressive neurosis: a placebo and standard (imipramine) controlled clinical study.
Topics: Adult; Anxiety; Clinical Trials as Topic; Depressive Disorder; Double-Blind Method; Female; Humans; | 1980 |
Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.
Topics: Adult; Anxiety; Depression; Double-Blind Method; Female; Humans; Hypochondriasis; Hysteria; Imiprami | 1980 |
Effects of moclobemide on depressive symptoms and cognitive performance in a geriatric population: a controlled comparative study versus imipramine.
Topics: Aged; Antidepressive Agents; Anxiety; Benzamides; Cognition; Depressive Disorder; Double-Blind Metho | 1994 |
Efficacy of venlafaxine in depressive illness in general practice.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyc | 1997 |
Depressed in-patients respond differently to imipramine and mirtazapine.
Topics: Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Antidepressive Agents, Tricyclic; Anxiety | 1999 |
Pharmacologic effect of imipramine, paroxetine, and sertraline on 35% carbon dioxide hypersensitivity in panic patients: a double-blind, random, placebo-controlled study.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Carbon Dioxide; Double-Blind Method; Female; Human | 1997 |
Short-term effects of three continuous hormone replacement therapy regimens on platelet tritiated imipramine binding and mood scores: a prospective randomized trial.
Topics: Affect; Alendronate; Anxiety; Blood Platelets; Estradiol; Estrogen Replacement Therapy; Estrogens, C | 2001 |
Which tricyclic for depressed outpatients, imipramine pamoate or amitriptyline?
Topics: Adjustment Disorders; Adult; Ambulatory Care; Amitriptyline; Anxiety; Clinical Trials as Topic; Depr | 1977 |
Trazodone, a new antidepressant: efficacy and safety in endogenous depression.
Topics: Adult; Aged; Anxiety; Clinical Trials as Topic; Depression; Double-Blind Method; Female; Humans; Imi | 1979 |
Doxepin versus imipramine in psychoneurotic depressed patients with sleep disturbance: a double-blind study.
Topics: Adjustment Disorders; Adult; Aged; Anxiety; Cognition; Double-Blind Method; Doxepin; Drug Evaluation | 1978 |
Maprotiline (Ludiomil, Ciba 34,276-BA) and imipramine in depressed outpatients: a double-blind clinical study.
Topics: Adult; Ambulatory Care; Analysis of Variance; Anthracenes; Antidepressive Agents; Anxiety; Clinical | 1976 |
The endogenous--neurotic distinction as a predictor of response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Antidepressive Agents; Anxiety; Chlorpromazine; Depre | 1976 |
Antidepressants in black and white inpatients. Differential response to a controlled trial of chlorpromazine and imipramine.
Topics: Adult; Age Factors; Anxiety; Black or African American; Chlorpromazine; Clinical Trials as Topic; De | 1975 |
Pretreatment anxiety level as differential predictor in outpatients with panic disorder.
Topics: Adult; Alprazolam; Anxiety; Female; Humans; Imipramine; Male; Outpatients; Panic Disorder; Prognosis | 1992 |
Imipramine and alprazolam effects on stress test reactivity in panic disorder.
Topics: Adult; Alprazolam; Anxiety; Arrhythmias, Cardiac; Blood Pressure; Carbon Dioxide; Cold Temperature; | 1992 |
Effects of alprazolam and imipramine on parasympathetic cardiac control in patients with generalized anxiety disorder.
Topics: Adult; Alprazolam; Anxiety; Arrhythmia, Sinus; Blood Pressure; Double-Blind Method; Female; Heart; H | 1992 |
The changes of thyroid hormone during pharmacological treatment of panic disorder patients.
Topics: Adult; Analysis of Variance; Anxiety; Chi-Square Distribution; Diazepam; Double-Blind Method; Female | 1991 |
Pharmacotherapy for posttraumatic stress disorder using phenelzine or imipramine.
Topics: Adult; Ambulatory Care; Anxiety; Depression; Double-Blind Method; Humans; Imipramine; Male; Personal | 1991 |
Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial.
Topics: Adult; Agoraphobia; Alprazolam; Analysis of Variance; Anxiety; Anxiety Disorders; Depression; Disabi | 1990 |
A comparison study of antidepressants and structured intensive group psychotherapy in the treatment of bulimia nervosa.
Topics: Adolescent; Adult; Anorexia Nervosa; Anxiety; Behavior Therapy; Body Weight; Bulimia; Cognitive Beha | 1990 |
A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
Topics: Adult; Agoraphobia; Alprazolam; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Clinical Trials as To | 1986 |
Clomipramine: an antiobsessive drug.
Topics: Anxiety; Behavior Therapy; Clinical Trials as Topic; Clomipramine; Compulsive Behavior; Depressive D | 1986 |
A comparison of fluoxetine, imipramine, and placebo in patients with major depressive disorder.
Topics: Adult; Ambulatory Care; Anxiety; Body Weight; Clinical Trials as Topic; Depressive Disorder; Dizzine | 1985 |
A review of multicenter controlled studies of fluoxetine vs. imipramine and placebo in outpatients with major depressive disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Ambulatory Care; Anxiety; Clinical Trials as Topic | 1985 |
Isoproterenol-induced anxiety states.
Topics: Anxiety; Female; Humans; Imipramine; Isoproterenol; Male; Panic | 1985 |
Clomipramine HCL--a double-blind study of a new antidepressant drug.
Topics: Adult; Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depression; Dibenzazepines; Evaluat | 1973 |
Clinical experience with a new psychotropic drug, trazodone: a review of literature.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depressio | 1973 |
A guide for drug use in depressive disorders.
Topics: Adolescent; Adult; Aged; Anxiety; Chlorpromazine; Clinical Trials as Topic; Depression; Diazepam; Dr | 1974 |
Effects of imipramine on individuals varying in level of depression.
Topics: Adult; Anxiety; Depression; Humans; Imipramine; Male; MMPI; Placebos | 1968 |
Effects of imipramine and dextroamphetamine on behavior of neuropsychiatrically impaired children.
Topics: Adolescent; Aggression; Anxiety; Brain Damage, Chronic; Child; Child Behavior Disorders; Clinical Tr | 1972 |
Iprindole and imipramine in non-psychotic depressed out-patients.
Topics: Adult; Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depression; Family Practice; Female | 1973 |
The comparative anxiolytic effects of placebo, imipramine and chlorimipramine using psychiatric and psychophysiological measurements.
Topics: Adolescent; Adult; Alanine Transaminase; Analysis of Variance; Anxiety; Aspartate Aminotransferases; | 1974 |
Butriptyline hydrochloride and imipramine hydrochloride in the treatment of non-psychotic depression. A double-blind trial.
Topics: Antidepressive Agents; Anxiety; Clinical Trials as Topic; Depression; Dibenzocycloheptenes; Humans; | 1974 |
Influence-possibilities on therapy-resistant late depressions.
Topics: Aged; Amitriptyline; Antidepressive Agents; Anxiety; Arteriosclerosis; Clinical Trials as Topic; Dep | 1974 |
Prediction of drug effect by diagnostic decision tree.
Topics: Anxiety; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic; Depression; Factor Analysis, St | 1968 |
A comparative trial of imipramine and chlorpromazine in depressed patients.
Topics: Adult; Analysis of Variance; Anxiety; Chlorpromazine; Clinical Trials as Topic; Depression; Female; | 1968 |
Comparison of imipramine and chlordiazepoxide in the treatment of the depressed and anxious patient.
Topics: Adolescent; Adult; Anxiety; Chlordiazepoxide; Clinical Trials as Topic; Depression; Female; Humans; | 1969 |
A comparative trial of imipramine and phenobarbital in depressed patients seen in general practice.
Topics: Adjustment Disorders; Adolescent; Adult; Aged; Anxiety; Child; Clinical Trials as Topic; Depression; | 1969 |
A comparison of two drug treatments in depressive illness.
Topics: Amitriptyline; Anxiety; Clinical Trials as Topic; Depression; Female; Humans; Imipramine; Male; Midd | 1969 |
A controlled study of nortriptyline and imipramine.
Topics: Anxiety; Body Weight; Clinical Trials as Topic; Depression; Female; Humans; Imipramine; Nortriptylin | 1970 |
Differential response to chlorpromazine, imipramine, and placebo. A study of subgroups of hospitalized depressed patients.
Topics: Adolescent; Adult; Age Factors; Aged; Anxiety; Chlorpromazine; Clinical Trials as Topic; Depression; | 1970 |
Comparison of the effect of imipramine and desipramine on some symptoms of depressive illness.
Topics: Adult; Anorexia Nervosa; Anxiety; Clinical Trials as Topic; Depression; Desipramine; Humans; Imipram | 1965 |
Effects of imipramine on anxiety and hostility levels.
Topics: Adult; Anxiety; Clinical Trials as Topic; Fear; Guilt; Hate; Humans; Hypochondriasis; Imipramine; Ma | 1965 |
Importance of psychiatric diagnosis in prediction of clinical drug effects.
Topics: Antisocial Personality Disorder; Anxiety; Bipolar Disorder; Chlorpromazine; Clinical Trials as Topic | 1967 |
Drugs and dreams 3. The effects of imipramine on the dreams of depressed patients.
Topics: Anxiety; Depression; Dreams; Eye Movements; Homosexuality; Hospitalization; Hostility; Humans; Imipr | 1968 |
147 other studies available for imipramine and Anxiety
| Article | Year |
|---|---|
Novel class of arylpiperazines containing N-acylated amino acids: their synthesis, 5-HT1A, 5-HT2A receptor affinity, and in vivo pharmacological evaluation.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amino Acids; Animals; Anti-Anxiety Agents; Antidepressive Ag | 2007 |
Synthesis and serotonin receptor activity of the arylpiperazine alkyl/propoxy derivatives of new azatricycloundecanes.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Mice; Receptor, Serotonin, 5-HT1A; Receptor, Se | 2009 |
In vitro structure-activity relationships of aplysinopsin analogs and their in vivo evaluation in the chick anxiety-depression model.
Topics: Animals; Antidepressive Agents; Anxiety; Behavior, Animal; Chickens; Depression; Disease Models, Ani | 2013 |
Imipramine-precipitated status epilepticus.
Topics: Antidepressive Agents, Tricyclic; Anxiety; Child; Diagnosis, Differential; Electroencephalography; F | 2021 |
Proteome profile of telencephalon associates attenuated neurogenesis with chronic stress induced mood disorder phenotypes in zebrafish model.
Topics: Affect; Animals; Antidepressive Agents; Anxiety; Cell Proliferation; Depression; Disease Models, Ani | 2021 |
Imipramine attenuates anxiety- and depressive-like effects of acute and prolonged ethanol-abstinence in male rats by modulating SERT and GR expression in the dorsal hippocampus.
Topics: Alcohol Abstinence; Animals; Anxiety; Behavior, Animal; Depression; Hippocampus; Imipramine; Male; R | 2021 |
Cariprazine Exhibits Anxiolytic and Dopamine D3 Receptor-Dependent Antidepressant Effects in the Chronic Stress Model.
Topics: Anhedonia; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Aripiprazole; Chronic Disea | 2017 |
The hemoglobin derived peptide LVV-hemorphin-7 evokes behavioral effects mediated by oxytocin receptors.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Diazepam | 2017 |
The anxiolytic-like effect of 6-styryl-2-pyrone in mice involves GABAergic mechanism of action.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Flumazenil; gamma-Aminobutyric Ac | 2018 |
Social stress induces neurovascular pathology promoting depression.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Behavior, Animal; Blood-Brain Barrier; Claudin-5; De | 2017 |
Garlic (
Topics: Animals; Antidepressive Agents; Antioxidants; Anxiety; Brain; Depressive Disorder; Diabetes Mellitus | 2020 |
Imipramine treatment reverses depressive- and anxiety-like behaviors, normalize adrenocorticotropic hormone, and reduces interleukin-1β in the brain of rats subjected to experimental periapical lesion.
Topics: Adrenocorticotropic Hormone; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; B | 2019 |
Role of 5-HT2C receptors of the dorsal hippocampus in the modulation of anxiety- and panic-related defensive responses in rats.
Topics: Aminopyridines; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Ethylamines; Hippocampus; | 2019 |
New evidence for refinement of anesthetic choice in procedures preceding the forced swimming test and the elevated plus-maze.
Topics: Anesthetics, General; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal | 2019 |
Involvement of 5-HT2C and 5-HT1A receptors of the basolateral nucleus of the amygdala in the anxiolytic effect of chronic antidepressant treatment.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Age | 2014 |
The effect of curcumin on the brain-gut axis in rat model of irritable bowel syndrome: involvement of 5-HT-dependent signaling.
Topics: Animals; Anxiety; Brain-Derived Neurotrophic Factor; Colon; Curcumin; Cyclic AMP Response Element-Bi | 2015 |
Chronic mild stress and imipramine treatment elicit opposite changes in behavior and in gene expression in the mouse prefrontal cortex.
Topics: Anhedonia; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Circadian Rhythm; G | 2015 |
The positive effect on ketamine as a priming adjuvant in antidepressant treatment.
Topics: Animals; Antidepressive Agents; Anxiety; Aspartic Acid; Behavior, Animal; Brain; Depression; Depress | 2015 |
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice.
Topics: Animals; Anxiety; Cannabidiol; Cell Proliferation; Dentate Gyrus; Dose-Response Relationship, Drug; | 2016 |
IL-4/10 prevents stress vulnerability following imipramine discontinuation.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Depression; Electroshock; Expl | 2015 |
The effect of chronic tianeptine administration on the brain mitochondria: direct links with an animal model of depression.
Topics: Animals; Anxiety; Behavior, Animal; Brain; Depression; Disease Models, Animal; Electrophoresis, Gel, | 2016 |
Antidepressant imipramine diminishes stress-induced inflammation in the periphery and central nervous system and related anxiety- and depressive- like behaviors.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Corticosterone; Depression; Im | 2016 |
The effects of Sceletium tortuosum (L.) N.E. Br. extract fraction in the chick anxiety-depression model.
Topics: Animals; Antidepressive Agents; Anxiety; Chickens; Depression; Disease Models, Animal; Imipramine; M | 2016 |
Modelling the anxiety-depression continuum in chicks.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Chickens; Chlordiaze | 2009 |
Anxiolytic-like effect of chronic treatment with Erythrina velutina extract in the elevated plus-maze test.
Topics: Administration, Oral; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Brazil; Chlordiazepox | 2008 |
Mouse strain differences in the unpredictable chronic mild stress: a four-antidepressant survey.
Topics: Animals; Animals, Outbred Strains; Antidepressive Agents; Antidepressive Agents, Second-Generation; | 2008 |
Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.
Topics: Affect; Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; | 2009 |
PUFA induce antidepressant-like effects in parallel to structural and molecular changes in the hippocampus.
Topics: alpha-Linolenic Acid; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Brain; B | 2009 |
Behavioral profile of P2X7 receptor knockout mice in animal models of depression and anxiety: relevance for neuropsychiatric disorders.
Topics: Analysis of Variance; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Depressi | 2009 |
CREB regulation of nucleus accumbens excitability mediates social isolation-induced behavioral deficits.
Topics: Adrenergic Uptake Inhibitors; Affective Symptoms; Animals; Anxiety; Behavior, Animal; CREB-Binding P | 2009 |
Deficit in BDNF does not increase vulnerability to stress but dampens antidepressant-like effects in the unpredictable chronic mild stress.
Topics: Aggression; Animals; Antidepressive Agents, Tricyclic; Anxiety; Body Weight; Brain-Derived Neurotrop | 2009 |
Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Arginine; Behavior, Animal; Cyclohexanols; Drug Synergism; | 2009 |
Social separation and diazepam withdrawal increase anxiety in the elevated plus-maze and serotonin turnover in the median raphe and hippocampus.
Topics: Acute Disease; Animals; Anti-Anxiety Agents; Anxiety; Avoidance Learning; Chronic Disease; Diazepam; | 2010 |
Transient early-life forebrain corticotropin-releasing hormone elevation causes long-lasting anxiogenic and despair-like changes in mice.
Topics: Adaptation, Ocular; Age Factors; Analysis of Variance; Animals; Animals, Newborn; Antidepressive Age | 2010 |
Pharmacological reversal of cognitive bias in the chick anxiety-depression model.
Topics: Analysis of Variance; Animals; Animals, Newborn; Antidepressive Agents; Anxiety; Bias; Chickens; Clo | 2012 |
Influence of Neuropeptide Y and antidepressants upon cerebral monoamines involved in depression: an in vivo electrochemical study.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anx | 2011 |
Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
Topics: 5,7-Dihydroxytryptamine; Adrenergic Agents; Adrenergic Uptake Inhibitors; Analysis of Variance; Anim | 2011 |
Effects of chronic corticosterone and imipramine administration on panic and anxiety-related responses.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Corticosterone; Escape Reactio | 2011 |
Assessment of anxiolytic and panicolytic effects of dichloromethane fraction from stems of Kielmeyera coriacea.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Clusiacea | 2012 |
Anhedonic-like traits and lack of affective deficits in 18-month-old C57BL/6 mice: Implications for modeling elderly depression.
Topics: Aging; Anhedonia; Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Depressive D | 2012 |
Effect of imipramine and prolyl endopeptidase inhibitor benzyloxycarbonyl-methionyl-2(S)-cyanopyrrolidine on activity of proline-specific peptidases in the brain of rats with experimental anxious-depressive syndrome.
Topics: Animals; Animals, Newborn; Antidepressive Agents, Tricyclic; Anxiety; Brain; Depressive Disorder; Di | 2012 |
Effects of sex and rearing environment on imipramine response in mice.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Calbindin 2; Calbindins; Disea | 2012 |
The neuronal insulin sensitizer dicholine succinate reduces stress-induced depressive traits and memory deficit: possible role of insulin-like growth factor 2.
Topics: Animals; Antidepressive Agents; Anxiety; Depression; Disease Models, Animal; Hippocampus; Imipramine | 2012 |
Pharmacological activity of hyperforin acetate in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Beha | 2002 |
Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Argin | 2003 |
[Significance of imipramine in the medico-psychopedagogical reduction of depressive behavior in the form of anxiety and inhibition].
Topics: Anxiety; Anxiety Disorders; Depression; Depressive Disorder; Imipramine; Psychopharmacology | 1961 |
[Post-imipramine anxiety. Its phenomenology-its treatment].
Topics: Anxiety; Anxiety Disorders; Humans; Imipramine; Psychopharmacology | 1961 |
[Ozena and nervous depression improved by imipramine].
Topics: Anxiety; Atrophy; Depression; Depressive Disorder; Humans; Imipramine; Psychopharmacology; Rhinitis; | 1960 |
DRUGS, DREAMS AND THE EXPERIMENTAL SUBJECT.
Topics: Anxiety; Dreams; Humans; Hypnosis; Imipramine; Phenobarbital; Prochlorperazine; Sexual Behavior; Sle | 1963 |
EFFECTS OF IMIPRAMINE UPON VARIOUS MENTAL SYNDROMES IN AMBULATORY TREATMENT.
Topics: Anxiety; Anxiety Disorders; Autonomic Nervous System Diseases; Dementia; Depression; Humans; Imipram | 1963 |
EVALUATION OF THE ANTIDEPRESSANT ACTION OF MELIPRAMINE.
Topics: Antidepressive Agents; Anxiety; Brain; Cats; Depression; Electrophysiology; Hypochondriasis; Imipram | 1963 |
PSYCHOPHARMACOLOGY OF IMIPRAMINE AND DESIPRAMINE: A COMPARATIVE STUDY OF THEIR EFFECTS IN NORMAL MALES.
Topics: Antidepressive Agents; Anxiety; Biomedical Research; Blood Pressure Determination; Cognition; Desipr | 1964 |
TREATMENT OF CHRONIC TENSION HEADACHE.
Topics: Amitriptyline; Amobarbital; Anxiety; Anxiety Disorders; Biomedical Research; Chlordiazepoxide; Diaze | 1964 |
[PECULIARITIES OF THE PHOTOERYTHEMIC SKIN REACTION IN PATIENTS WITH MANIC-DEPRESSIVE CONDITIONS AND ITS DYNAMICS DURING THE COURSE OF TREATMENT].
Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Chlorpromazine; Depression; Depressive Disorder; Depre | 1963 |
[BARBAMYL-TOFRANIL TEST IN THE EVALUATION OF THE DEPRESSIVE STATE].
Topics: Amobarbital; Anxiety; Anxiety Disorders; Bipolar Disorder; Delirium; Delusions; Depression; Depressi | 1963 |
DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES.
Topics: Anxiety; Anxiety Disorders; Biomedical Research; Chlorpromazine; Imipramine; Parasympatholytics; Pla | 1964 |
[PSYCHOPHARMACOLOGICAL EXPERIENCES WITH IMIPRAMINE, WITH SPECIAL REFERENCE TO LEONHARD'S CLASSIFICATION OF ENDOGENOUS PSYCHOSES].
Topics: Anxiety; Anxiety Disorders; Bipolar Disorder; Depression; Depressive Disorder; Drug Therapy; Humans; | 1964 |
Use of the elevated T-maze to study anxiety in mice.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Antagonists; Analysis of Variance; Animals; | 2004 |
Is agmatine an endogenous anxiolytic/antidepressant agent?
Topics: Agmatine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Depression | 2003 |
Harmane induces anxiolysis and antidepressant-like effects in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Depression; Dose-Res | 2003 |
Reduced anxiety and depression-like behavior in synaptotagmin IV (-/-) mice.
Topics: Animals; Anxiety; Calcium-Binding Proteins; Depression; Female; Imipramine; Male; Membrane Glycoprot | 2004 |
Does rat global transient cerebral ischemia serve as an appropriate model to study emotional disturbances?
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Depression; Diazepam; Disea | 2004 |
Effects of a selective 5-HT1B receptor agonist and antagonists in animal models of anxiety and depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Benzamide | 2004 |
Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Amphetamines; Animals; Antidepressive Agents, Tricyclic; Anx | 2005 |
Evaluation of two genetic animal models in behavioral tests of anxiety and depression.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Depression; Factor Analysis, S | 2006 |
Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Behav | 2006 |
Modeling the anxiety-depression continuum hypothesis in domestic fowl chicks.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Chickens; | 2006 |
Efficacy of the MCHR1 antagonist N-[3-(1-{[4-(3,4-difluorophenoxy)phenyl]methyl}(4-piperidyl))-4-methylphenyl]-2-methylpropanamide (SNAP 94847) in mouse models of anxiety and depression following acute and chronic administration is independent of hippocam
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antimetabolit | 2007 |
Effects of the brain-penetrant and selective 5-HT6 receptor antagonist SB-399885 in animal models of anxiety and depression.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Tricyclic; Anxiety; Avoi | 2007 |
Anxiolytic-like and antidepressant-like effects produced by the selective 5-HT6 receptor antagonist SB-258585 after intrahippocampal administration to rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Depression; Diazepam; Disease Models, | 2007 |
Chronic low dose corticosterone exposure decreased hippocampal cell proliferation, volume and induced anxiety and depression like behaviours in mice.
Topics: Adrenal Glands; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; | 2008 |
What happens to the psychiatric office patient treated with drugs? A follow-up study.
Topics: Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpromazine; Deanol; Family | 1967 |
Neurotransmitters and receptors: clinical implications.
Topics: Anxiety; Binding Sites; Depressive Disorder; Humans; Imipramine; Mental Disorders; Neurotransmitter | 1984 |
[Pharmaco-ethological analysis of agonistic behavior between resident and intruder mice: effects of psychotropic drugs].
Topics: Aggression; Agonistic Behavior; Animals; Anxiety; Chlordiazepoxide; Female; Haloperidol; Hostility; | 1984 |
[Semeiology of anxiety].
Topics: Adult; Aged; Anxiety; Anxiety, Separation; Child, Preschool; Humans; Imipramine; Infant; Infant, New | 1983 |
Serum dopamine-beta-hydroxylase activity in depression and anxiety.
Topics: Adult; Aged; Alprazolam; Anxiety; Anxiety Disorders; Benzodiazepines; Depression; Depressive Disorde | 1984 |
The treatment of sexual phobias: the combined use of antipanic medication and sex therapy.
Topics: Adult; Antidepressive Agents, Tricyclic; Anxiety; Female; Humans; Imipramine; Male; Monoamine Oxidas | 1982 |
Differential modulation of antipredator defensive behavior in Swiss-Webster mice following acute or chronic administration of imipramine and fluoxetine.
Topics: Animals; Anxiety; Avoidance Learning; Behavior, Animal; Fluoxetine; Imipramine; Male; Mice; Mice, In | 1995 |
A comparison of the acute effects of a tricyclic and a MAOI antidepressant on septal driving of hippocampal rhythmical slow activity.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Brain; Electric Stimulation | 1994 |
Acute and chronic treatment with 5-HT reuptake inhibitors differentially modulate emotional responses in anxiety models in rodents.
Topics: Animals; Anxiety; Citalopram; Emotions; Exploratory Behavior; Imipramine; Male; Mice; Motor Activity | 1994 |
Attenuation of antipredator defensive behavior in rats following chronic treatment with imipramine.
Topics: Aggression; Animals; Anxiety; Cats; Consummatory Behavior; Depression, Chemical; Drinking Behavior; | 1993 |
TJS-010, a new prescription of Kampo medicine with putative antidepressive and anxiolytic properties.--A behavioral study using experimental models for depression and anxiety.
Topics: Administration, Oral; Animals; Anxiety; Depression; Disease Models, Animal; Drugs, Chinese Herbal; H | 1994 |
Ethological comparison of the effects of diazepam and acute/chronic imipramine on the behaviour of mice in the elevated plus-maze.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Diazepam; Imipramine; Male; Mice; Mice, Inb | 1995 |
Effect of imipramine treatments on the 5-HT1A-receptor-mediated inhibition of panic-like behaviours in rats.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Analysis of Variance; Animals; Antidepressive Agents, Tricyc | 1997 |
[Opipramol in behavioral pharmacologic anxiety and depression models].
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Benzodiazepines; Depressive | 1998 |
Depressive state with anxiety in repeated cold-stressed mice in forced swimming tests.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Behavior, Animal; Cold Temperature; De | 1999 |
Effects of rolipram on the elevated plus-maze test in rats: a preliminary study.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; | 1999 |
Behavioral effects of acute and chronic imipramine in the elevated T-maze model of anxiety.
Topics: Animals; Antidepressive Agents, Tricyclic; Anxiety; Behavior, Animal; Exploratory Behavior; Habituat | 2000 |
Flibanserin has anxiolytic effects without locomotor side effects in the infant rat ultrasonic vocalization model of anxiety.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Benzimidazoles; Body | 2000 |
Inhibition of stress- or anxiogenic-drug-induced increases in dopamine release in the rat prefrontal cortex by long-term treatment with antidepressant drugs.
Topics: Animals; Antidepressive Agents; Anxiety; Carbolines; Dopamine; Dose-Response Relationship, Drug; Dru | 2001 |
The alpha(2a)-adrenergic receptor plays a protective role in mouse behavioral models of depression and anxiety.
Topics: Adrenergic Uptake Inhibitors; Animals; Anxiety; Behavior, Animal; Darkness; Depression; Disease Mode | 2001 |
Chronic treatment with imipramine or mirtazapine antagonizes stress- and FG7142-induced increase in cortical norepinephrine output in freely moving rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Tricyclic; Anxiety; Carbolines; Cerebral Cortex | 2002 |
Anxiolytic- and antidepressant-like effects of the non-peptide vasopressin V1b receptor antagonist, SSR149415, suggest an innovative approach for the treatment of stress-related disorders.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antid | 2002 |
Night terrors. A review of the psychology, neurophysiology, and therapy.
Topics: Adolescent; Anxiety; Child; Child, Preschool; Diazepam; Electroencephalography; Humans; Imipramine; | 1975 |
The use of psychoactive drugs in the long-term treatment of chronic alcoholics.
Topics: Alcoholism; Anti-Anxiety Agents; Antipsychotic Agents; Anxiety; Chlordiazepoxide; Chlorpromazine; Ch | 1975 |
[Treatment modalities in sleep disorder--neurophysiological introduction and behavior modification (author's transl)].
Topics: Antidepressive Agents; Anxiety; Behavior Therapy; Child; Enuresis; Humans; Imipramine; Nervous Syste | 1979 |
Rapid opiate detoxification: clinical evidence of antidepressant and antipanic effects of opiates.
Topics: Adult; Anxiety; Clonidine; Depression; Drug Therapy, Combination; Fear; Humans; Imipramine; Male; Me | 1979 |
Case 1. Assessment and treatment of phobic anxiety.
Topics: Adjustment Disorders; Adult; Agoraphobia; Anxiety; Behavior Therapy; Diagnosis, Differential; Female | 1979 |
The physician's knowledge of psychotropic drugs: preliminary results.
Topics: Amitriptyline; Anxiety; Clinical Competence; Depression; Diazepam; Humans; Imipramine; Internal Medi | 1978 |
Evaluating antianxiety agents in humans: experimental paradigms.
Topics: Anxiety; Avoidance Learning; Chlorpromazine; Conditioning, Operant; Dextroamphetamine; Diazepam; Dru | 1977 |
Antidepressant drugs.
Topics: Age Factors; Amitriptyline; Antidepressive Agents; Anxiety; Arrhythmias, Cardiac; Bipolar Disorder; | 1975 |
Patterns of symptom change in anxious depressed outpatients treated with different drugs.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Chlorpromazine; Depression; Desipra | 1975 |
The treatment of night terrors associated with The posttraumatic syndrome.
Topics: Administration, Oral; Adult; Anxiety; Arousal; Dreams; Fear; Heart Rate; Humans; Imipramine; Male; M | 1975 |
Psychological medicine. Management of depression.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Clomipramine; Depression; Drug Interactions; Electroc | 1975 |
Drug and psychotherapy interactions in depression.
Topics: Anxiety; Attitude; Depression; Diazepam; Drug Therapy, Combination; Employment; Estrogens; Female; H | 1976 |
Platelet [3H]imipramine binding in migraine and tension headache in relation to depression.
Topics: Adult; Anxiety; Blood Platelets; Carrier Proteins; Depression; Female; Headache; Humans; Imipramine; | 1991 |
A model to measure anticipatory anxiety in mice?
Topics: Animals; Anxiety; Body Temperature; Diazepam; Haloperidol; Imipramine; Male; Mice; Models, Psycholog | 1989 |
Can anti-panic drugs antagonise the anxiety produced in the rat by drugs acting at the GABA-benzodiazepine receptor complex?
Topics: Animals; Anxiety; Carbolines; Clonidine; Fear; Imipramine; Male; Panic; Pentylenetetrazole; Rats; Ra | 1987 |
Chronic treatment with imipramine does not reverse the effects of 3 anxiogenic compounds in a test of anxiety in the rat.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Carbolines; Drug Combinations; Imipramine; Male; Pentylenetet | 1987 |
[Chemotherapy principles of severe somatic expressions of anxiety in adolescents].
Topics: Adolescent; Alprazolam; Anxiety; Female; Humans; Imipramine; Somatoform Disorders | 1988 |
[Sleep deprivation as a method of treating endogenous depression].
Topics: Adult; Amitriptyline; Anxiety; Depersonalization; Depressive Disorder; Diazepam; Female; Humans; Imi | 1985 |
Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in rats.
Topics: Acoustic Stimulation; Animals; Anxiety; Fear; Imipramine; Male; Models, Psychological; Panic; Rats; | 1985 |
Biological stress responses in high and low trait anxious students.
Topics: Adolescent; Adult; Anxiety; Blood Platelets; Educational Measurement; Glycols; Humans; Imipramine; M | 1985 |
Adverse reactions to the tricyclic-antidepressant drugs. Report from Boston Collaborative Drug Surveillance Program.
Topics: Amitriptyline; Anxiety; Arrhythmias, Cardiac; Cardiovascular Diseases; Depression; Female; Heart; Hu | 1972 |
Pain patterns in the rheumatic disorders.
Topics: Anxiety; Arthritis; Arthritis, Rheumatoid; Aspirin; Chronic Disease; Depression; Giant Cell Arteriti | 1972 |
Rapidity of response to the treatment of enuresis.
Topics: Age Factors; Anxiety; Behavior Therapy; Child; Conditioning, Classical; Enuresis; Female; Humans; Im | 1973 |
[Study of a trial method specific for anxiolytics].
Topics: Animals; Anxiety; Behavior, Animal; Blood Pressure; Chlordiazepoxide; Diazepam; Dogs; Humans; Imipra | 1970 |
Drug therapy in alcoholism.
Topics: Adult; Alcoholic Intoxication; Alcoholism; Antidepressive Agents; Anxiety; Carbamates; Chlordiazepox | 1970 |
Night terrors.
Topics: Adult; Anxiety; Child; Darkness; Diazepam; Electroencephalography; Fear; Humans; Imipramine; Respira | 1974 |
Outpatient group therapy with geriatric patients.
Topics: Aged; Amitriptyline; Antidepressive Agents; Anxiety; Depression; Female; Geriatrics; Humans; Imipram | 1967 |
Activity of antihistamines in laboratory antidepressant tests.
Topics: Amitriptyline; Animals; Anxiety; Blepharoptosis; Cyproheptadine; Drug Synergism; Histamine H1 Antago | 1969 |
[Self- and foreign placements of current condition in psychopharmacological longitudinal studies].
Topics: Adolescent; Aggression; Alcoholism; Antiparkinson Agents; Anxiety; Depression; Drug Evaluation; Extr | 1974 |
Combined thyroid (triiodothyronine)-tricyclic antidepressant treatment in depressive states.
Topics: Adjustment Disorders; Adult; Amitriptyline; Antidepressive Agents; Anxiety; Bipolar Disorder; Blood | 1974 |
Biochemical criteria for classifying depressive disorders and predicting responses to pharmacotherapy: preliminary findings from studies of norepinephrine metabolism. Contributions to biochemistry.
Topics: Adolescent; Adult; Aged; Amitriptyline; Amphetamine; Anxiety; Bipolar Disorder; Brain; Depression; F | 1974 |
Plasma cortisol-binding capacity in mental illness.
Topics: Adult; Anxiety; Binding Sites; Bipolar Disorder; Chlorpromazine; Chromatography, Gel; Depression; Di | 1973 |
Benzodiazepines and anxiety states.
Topics: Amobarbital; Anxiety; Benzazepines; Chlordiazepoxide; Humans; Imipramine; Phenobarbital | 1973 |
Enuresis again.
Topics: Age Factors; Anxiety; Child; Child, Preschool; Conditioning, Psychological; Enuresis; Humans; Imipra | 1973 |
The treatment of depression with a single daily dose of imipramine pamoate.
Topics: Administration, Oral; Adult; Anxiety; Delayed-Action Preparations; Depression; Evaluation Studies as | 1973 |
Enuresis.
Topics: Anxiety; Child; Child, Preschool; Counseling; Enuresis; Exercise Therapy; Humans; Imipramine; Parent | 1973 |
Imipramine withdrawal: an akathisia-like syndrome.
Topics: Adult; Anxiety; Brain Chemistry; Dopamine; Female; Humans; Imipramine; Male; Middle Aged; Motor Acti | 1973 |
Age-sex differences in response to antidepressant drugs.
Topics: Adjustment Disorders; Adolescent; Adult; Age Factors; Aged; Antidepressive Agents; Anxiety; Chlorpro | 1974 |
Treatment of the depressed outpatient.
Topics: Adolescent; Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety; Child; Chlordiazepoxide; Dep | 1974 |
[Study of depressive states following the intake of appetite depressants].
Topics: Adolescent; Adult; Anxiety; Appetite Depressants; Depression; Female; Humans; Imipramine; Male; Midd | 1972 |
A behavior rating scale for assessing improvement in behaviorally deviant children: a preliminary investigation.
Topics: Adolescent; Aggression; Anxiety; Attention; Child; Child Behavior Disorders; Dextroamphetamine; Diag | 1972 |
Phobic anxiety syndrome complicated by drug dependence and addiction. A treatable form of drug abuse.
Topics: Adult; Anxiety; Electroconvulsive Therapy; Ethanol; Evaluation Studies as Topic; Female; Hospitaliza | 1972 |
[Basic deliberations on empiric methodology in psychiatry].
Topics: Anxiety; Depression; Humans; Imipramine; Methods; Psychiatry; Research; Speech | 1972 |
The use of psychopharmacological drugs in the aged.
Topics: Affective Symptoms; Aged; Antidepressive Agents; Anxiety; Barbiturates; Butyrophenones; Dementia; De | 1971 |
Drug treatment of chronic intractable pain in patients referred to a psychiatry clinic.
Topics: Adolescent; Adult; Aged; Amitriptyline; Anxiety; Chlordiazepoxide; Chronic Disease; Depression; Fema | 1971 |
[Hidden depression--problem in internal medicine].
Topics: Anxiety; Depression; Fatigue; Feeding and Eating Disorders; Humans; Imipramine; Psychophysiologic Di | 1970 |
[Preliminary observations using I.H.B. 215 on depressive-anxiety states].
Topics: Adult; Aged; Anxiety; Chlordiazepoxide; Depression; Female; Humans; Imipramine; Male; Middle Aged | 1969 |
[The effect of melipramine on the clinical picture and course of manic-depressive psychosis].
Topics: Adolescent; Adult; Aged; Anxiety; Bipolar Disorder; Communicable Diseases; Craniocerebral Trauma; De | 1969 |
Antianxiety and anti-depressant drugs.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Chlordiazepoxide; Depression; Desipramine; Dibenzoxep | 1970 |
Clinical and metabolic studies with imipramine in man.
Topics: Anxiety; Depression; Dextroamphetamine; Female; Humans; Imipramine; Male; Methylphenidate; Psychiatr | 1971 |
Allergy sympton survey. Evaluation of emotional content in allergy.
Topics: Anxiety; Chlordiazepoxide; Depression; Humans; Hypersensitivity; Imipramine; Psychophysiologic Disor | 1968 |
Anxiety attacks with subsequent agoraphobia.
Topics: Adolescent; Adult; Anxiety; Behavior Therapy; Female; Humans; Imipramine; Male; Phobic Disorders; Se | 1969 |
Drugs for patients with concurrent anxiety and depression.
Topics: Amitriptyline; Antidepressive Agents; Anxiety; Depression; Humans; Imipramine; Phenelzine | 1969 |
New treatment of some chronic tension states.
Topics: Adult; Aged; Amitriptyline; Antidepressive Agents; Anxiety; Chlorpromazine; Depression; Electroconvu | 1966 |